今日肿瘤学最高分文献 - 2025-03-21

Hey there, lab enthusiasts! Boost your research efficiency with AI-powered literature insights at your fingertips. Download the科研喵app, available at labcat.com.cn, and get ready to multiply your productivity. In yesterday's top article from Clinical Microbiology Reviews, researchers delve into the intricacies of BCG therapy for non-muscle-invasive bladder cancer. Despite decades of use, BCG's mechanisms remain elusive, and resistance is a growing concern. This comprehensive review breaks down BCG's direct tumor effects and its complex dance with the bladder tumor microenvironment, including its intriguing interaction with the bladder microbiome. The study also spotlights novel strategies to overcome BCG resistance, from recombinant BCG to microbiota-targeted therapies, aiming to enhance treatment efficacy and reduce side effects. As the only bacterial drug approved for cancer treatment, BCG's lessons could pave the way for the next generation of bacterial cancer therapies. Tune in for a deep dive into this fascinating frontier of cancer research!